126 related articles for article (PubMed ID: 32561788)
1. Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma.
de Carvalho AC; Perdomo S; Dos Santos W; Fernandes GC; de Jesus LM; Carvalho RS; Scapulatempo-Neto C; de Almeida GC; Sorroche BP; Arantes LMRB; Melendez ME; De Marchi P; Hayes N; Reis RM; Carvalho AL
Sci Rep; 2020 Jun; 10(1):9970. PubMed ID: 32561788
[TBL] [Abstract][Full Text] [Related]
2. Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status.
Reder H; Wagner S; Wuerdemann N; Langer C; Sandmann S; Braeuninger A; Dugas M; Gattenloehner S; Wittekindt C; Klussmann JP
Cancer Med; 2021 Feb; 10(4):1347-1356. PubMed ID: 33527763
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations in human papillomavirus-associated oropharyngeal squamous cell carcinoma of patients with treatment failure.
Reder H; Wagner S; Gamerdinger U; Sandmann S; Wuerdemann N; Braeuninger A; Dugas M; Gattenloehner S; Klussmann JP; Wittekindt C
Oral Oncol; 2019 Jun; 93():59-65. PubMed ID: 31109697
[TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx.
Dogan S; Xu B; Middha S; Vanderbilt CM; Bowman AS; Migliacci J; Morris LGT; Seshan VE; Ganly I
Int J Cancer; 2019 Dec; 145(11):3152-3162. PubMed ID: 31093971
[TBL] [Abstract][Full Text] [Related]
5. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
Nakagawa T; Matsusaka K; Misawa K; Ota S; Fukuyo M; Rahmutulla B; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Okamoto Y; Kaneda A
Int J Cancer; 2020 May; 146(9):2460-2474. PubMed ID: 31997344
[TBL] [Abstract][Full Text] [Related]
6. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.
Kylmä AK; Tolvanen TA; Carpén T; Haglund C; Mäkitie A; Mattila PS; Grenman R; Jouhi L; Sorsa T; Lehtonen S; Hagström J
Exp Mol Pathol; 2020 Jun; 114():104435. PubMed ID: 32240617
[TBL] [Abstract][Full Text] [Related]
7. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
8. DNA-Pk
Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
[TBL] [Abstract][Full Text] [Related]
9. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
Hufbauer M; Maltseva M; Meinrath J; Lechner A; Beutner D; Huebbers CU; Akgül B
Int J Cancer; 2018 Sep; 143(6):1426-1439. PubMed ID: 29663357
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials.
Rietbergen MM; Brakenhoff RH; Bloemena E; Witte BI; Snijders PJ; Heideman DA; Boon D; Koljenovic S; Baatenburg-de Jong RJ; Leemans CR
Ann Oncol; 2013 Nov; 24(11):2740-5. PubMed ID: 23946330
[TBL] [Abstract][Full Text] [Related]
11. Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation.
Tinhofer I; Stenzinger A; Eder T; Konschak R; Niehr F; Endris V; Distel L; Hautmann MG; Mandic R; Stromberger C; Weichert W; Budach V
Ann Oncol; 2016 Dec; 27(12):2262-2268. PubMed ID: 27681865
[TBL] [Abstract][Full Text] [Related]
12. The Role of Surgery in the Management of Recurrent Oropharyngeal Cancer.
Gross ND; Hanna EY
Recent Results Cancer Res; 2017; 206():197-205. PubMed ID: 27699540
[TBL] [Abstract][Full Text] [Related]
13. PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation.
Beaty BT; Moon DH; Shen CJ; Amdur RJ; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman TG; Thorp B; Blumberg JM; Patel SN; Weissler MC; Yarbrough WG; Sheets NC; Parker JS; Neil Hayes D; Weck KE; Ramkissoon LA; Mendenhall WM; Dagan R; Tan X; Gupta GP; Chera BS
J Natl Cancer Inst; 2020 Aug; 112(8):855-858. PubMed ID: 31747025
[TBL] [Abstract][Full Text] [Related]
14. Mutation and Transcriptional Profiling of Formalin-Fixed Paraffin Embedded Specimens as Companion Methods to Immunohistochemistry for Determining Therapeutic Targets in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Pilot of Proof of Principle.
Saba NF; Wilson M; Doho G; DaSilva J; Benjamin Isett R; Newman S; Chen ZG; Magliocca K; Rossi MR
Head Neck Pathol; 2015 Jun; 9(2):223-35. PubMed ID: 25236499
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
16. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
[TBL] [Abstract][Full Text] [Related]
18. Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma.
Kylmä AK; Jouhi L; Listyarifah D; Mohamed H; Mäkitie A; Remes SM; Haglund C; Atula T; Nieminen MT; Sorsa T; Hagström J
Br J Cancer; 2018 Jul; 119(1):89-95. PubMed ID: 29930251
[TBL] [Abstract][Full Text] [Related]
19. From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.
Boscolo-Rizzo P; Pawlita M; Holzinger D
Cancer Treat Rev; 2016 Jan; 42():24-9. PubMed ID: 26547133
[TBL] [Abstract][Full Text] [Related]
20. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
